ImaRx starts stroke trial for ultrasound/nanobubble combo
This article was originally published in Clinica
Executive Summary
ImaRx Therapeutics has begun a phase II human trial of its ultrasound-based method of clearing blood clots in patients with acute ischaemic stroke.